inVentiv Health Clinical's Late Stage leaders help world class companies bridge the gap from development to commercialization. The key is recognizing that Phase IIIb/IV research is conducted for different reasons than pre-approval studies. Post-approval success is achieved through documentation and persuasive demonstration of safety and value - and through an operational approach that reflects the unique characteristics of Late Stage studies: different goals, different measures, different stakeholders, and different timeframes.
Click here for more information.